Metagenomi Inc (MGX)

$1.88 -0.05 (-2.59%)
Market Cap 72.44M
Revenue (ttm) 52.30M
Net Income (ttm) -78.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -149.25%
Debt to Equity Ratio 0.00
Volume 218,900
Avg Vol 690,836
Day's Range N/A - N/A
Shares Out 37.53M
Stochastic %K 43%
Beta -0.12
Analysts Strong Sell
Price Target $11.80

Company Profile

Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medic...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 871 4880
Address:
5959 Horton Street, 7th Floor, EmeryVille, United States
erevnon
erevnon Aug. 19 at 12:37 PM
HC Wainwright & Co. reiterates Metagenomi $MGX at Buy and maintains the price target at https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Aug. 19 at 11:00 AM
HC Wainwright & Co. updates rating for Metagenomi ( $MGX ) to Buy, target set at 7.
0 · Reply
JarvisFlow
JarvisFlow Aug. 14 at 2:21 PM
Wells Fargo updates rating for Metagenomi ( $MGX ) to Overweight, target set at 16 → 12.
0 · Reply
d_risk
d_risk Aug. 13 at 6:12 AM
$MGX - Metagenomi Inc. Common Stock - 10Q - Updated Risk Factors MGX’s latest 10-Q risk factors spotlight heavy reliance on IP protection, new securities litigation and public perception risks, expanded compliance and regulatory hurdles, detailed financial and commercialization challenges, streamlined patent and collaboration risks, and fresh warnings on stock volatility, banking sector instability, and exclusive forum bylaws. #Biotechnology #FinancialRisk #RegulatoryCompliance #SecuritiesLitigation #IntellectualProperty 🟢 Added 🟠 Removed https://d-risk.ai/MGX/10-Q/2025-08-12
0 · Reply
MikeEhrmantraut
MikeEhrmantraut Aug. 11 at 5:56 PM
$MGX added few more for LT hold
0 · Reply
8008track
8008track Aug. 6 at 4:17 PM
$MGX does the new ban on mRNA vaccines impact this in any way? Serious question from a noobie.
1 · Reply
MikeEhrmantraut
MikeEhrmantraut Aug. 6 at 3:33 PM
$MGX adding to position for LT hold
0 · Reply
Diverstj981
Diverstj981 Aug. 6 at 2:53 PM
$MGX This loves going down. Ooof!
0 · Reply
I_am_retail_investor
I_am_retail_investor Aug. 4 at 11:49 PM
$MGX - # watchers just hit triple-seven, that means jumbo outsized gains forthcoming to $MGX going to $7.77
0 · Reply
I_am_retail_investor
I_am_retail_investor Jul. 29 at 5:38 PM
$MGX - won’t apologize if I offend the Trump voters on this thread, pretty stupid to be messing with the US patent system
0 · Reply
Latest News on MGX
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results

Aug 12, 2025, 4:05 PM EDT - 13 days ago

Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results

Metagenomi Appoints Laurence Reid, PhD to its Board of Directors

Aug 11, 2025, 4:05 PM EDT - 14 days ago

Metagenomi Appoints Laurence Reid, PhD to its Board of Directors

KALV

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

May 14, 2025, 6:00 AM EDT - 3 months ago

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

Metagenomi Reports Business Updates and First Quarter 2025 Financial Results

May 13, 2025, 4:30 PM EDT - 3 months ago

Metagenomi Reports Business Updates and First Quarter 2025 Financial Results

Metagenomi to Present at Upcoming Scientific Meetings

May 2, 2025, 7:00 AM EDT - 4 months ago

Metagenomi to Present at Upcoming Scientific Meetings

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

Mar 17, 2025, 4:05 PM EDT - 5 months ago

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

Mar 13, 2025, 6:19 AM EDT - 5 months ago

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

Feb 11, 2025, 8:55 AM EST - 6 months ago

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

Jan 16, 2025, 8:55 AM EST - 7 months ago

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

Metagenomi Announces New Appointment to its Board of Directors

Jan 15, 2025, 8:55 AM EST - 7 months ago

Metagenomi Announces New Appointment to its Board of Directors

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 4:05 PM EST - 8 months ago

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

Dec 11, 2024, 6:30 PM EST - 9 months ago

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Dec 9, 2024, 9:16 PM EST - 9 months ago

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Nov 25, 2024, 11:30 AM EST - 9 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Nov 25, 2024, 9:56 AM EST - 9 months ago

FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Nov 24, 2024, 9:37 AM EST - 9 months ago

MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Assist The Schall Law Firm

Nov 23, 2024, 5:15 PM EST - 9 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Assist The Schall Law Firm

MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit

Nov 23, 2024, 1:00 PM EST - 9 months ago

MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit

DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024

Nov 22, 2024, 11:59 AM EST - 9 months ago

DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Nov 21, 2024, 12:00 PM EST - 9 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Shareholders of Metagenomi, Inc. Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights – MGX

Nov 20, 2024, 12:41 PM EST - 9 months ago

Shareholders of Metagenomi, Inc. Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights – MGX

The Schall Law Firm Invites Investor Participation In A Fraud Case Against Metagenomi Inc

Nov 20, 2024, 11:00 AM EST - 9 months ago

The Schall Law Firm Invites Investor Participation In A Fraud Case Against Metagenomi Inc

The Schall Law Firm Invites Investors To Join A Fraud Case Against Metagenomi Inc

Nov 18, 2024, 1:30 PM EST - 10 months ago

The Schall Law Firm Invites Investors To Join A Fraud Case Against Metagenomi Inc

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Nov 17, 2024, 3:00 PM EST - 10 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Nov 14, 2024, 9:18 PM EST - 10 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Metagenomi, Inc. Is Being Sued For Violating Securities Regulations And Shareholders With Losses Are Urged To Help The Schall Law Firm

Nov 13, 2024, 1:15 PM EST - 10 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Regulations And Shareholders With Losses Are Urged To Help The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Nov 11, 2024, 4:00 PM EST - 10 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Assist The Schall Law Firm

Nov 11, 2024, 2:45 PM EST - 10 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Assist The Schall Law Firm

Metagenomi, Inc. May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Nov 9, 2024, 12:30 PM EST - 10 months ago

Metagenomi, Inc. May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

erevnon
erevnon Aug. 19 at 12:37 PM
HC Wainwright & Co. reiterates Metagenomi $MGX at Buy and maintains the price target at https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Aug. 19 at 11:00 AM
HC Wainwright & Co. updates rating for Metagenomi ( $MGX ) to Buy, target set at 7.
0 · Reply
JarvisFlow
JarvisFlow Aug. 14 at 2:21 PM
Wells Fargo updates rating for Metagenomi ( $MGX ) to Overweight, target set at 16 → 12.
0 · Reply
d_risk
d_risk Aug. 13 at 6:12 AM
$MGX - Metagenomi Inc. Common Stock - 10Q - Updated Risk Factors MGX’s latest 10-Q risk factors spotlight heavy reliance on IP protection, new securities litigation and public perception risks, expanded compliance and regulatory hurdles, detailed financial and commercialization challenges, streamlined patent and collaboration risks, and fresh warnings on stock volatility, banking sector instability, and exclusive forum bylaws. #Biotechnology #FinancialRisk #RegulatoryCompliance #SecuritiesLitigation #IntellectualProperty 🟢 Added 🟠 Removed https://d-risk.ai/MGX/10-Q/2025-08-12
0 · Reply
MikeEhrmantraut
MikeEhrmantraut Aug. 11 at 5:56 PM
$MGX added few more for LT hold
0 · Reply
8008track
8008track Aug. 6 at 4:17 PM
$MGX does the new ban on mRNA vaccines impact this in any way? Serious question from a noobie.
1 · Reply
MikeEhrmantraut
MikeEhrmantraut Aug. 6 at 3:33 PM
$MGX adding to position for LT hold
0 · Reply
Diverstj981
Diverstj981 Aug. 6 at 2:53 PM
$MGX This loves going down. Ooof!
0 · Reply
I_am_retail_investor
I_am_retail_investor Aug. 4 at 11:49 PM
$MGX - # watchers just hit triple-seven, that means jumbo outsized gains forthcoming to $MGX going to $7.77
0 · Reply
I_am_retail_investor
I_am_retail_investor Jul. 29 at 5:38 PM
$MGX - won’t apologize if I offend the Trump voters on this thread, pretty stupid to be messing with the US patent system
0 · Reply
MikeEhrmantraut
MikeEhrmantraut Jul. 29 at 3:58 PM
$MGX adding a few more on this dip. Trading less than 50% cash.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 10:15 PM
$MGX Brilliant piece that captures MGX's situation perfectly. So if you want to update your understanding of MGX or get to know MGX better, this is essential reading. https://beyondspx.com/article/metagenomi-unlocking-genetic-potential-with-a-deep-toolbox-nasdaq-mgx
0 · Reply
MikeEhrmantraut
MikeEhrmantraut Jul. 28 at 7:52 PM
$MGX I don’t put much faith into charts but the YTD chart has a nice cup and handle forming
0 · Reply
MikeEhrmantraut
MikeEhrmantraut Jul. 28 at 7:46 PM
$MGX LT hold here. Potential 10-100x bagger
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 28 at 5:39 PM
$MGX has reversed -3% lower to 5% (~1Mv) a few minutes ago, follow for more volatility.
0 · Reply
Rolo2024
Rolo2024 Jul. 28 at 3:28 PM
$MGX Great financials!
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 25 at 1:42 PM
$IPA 15%[0%] $ZYXI 6%[0%] $MGX -6%[-5%] $PHIO 6%[25%] $PL -5%[-1%] most notable movement within the first minutes of trading.
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 24 at 7:52 PM
$TLIH 6%[-74%] $PHOE -6%[25%] $MGX -4%[6%] $UCAR 4%[-23%] $CRE 3%[11%] most notable movement into the final minutes of trading.
0 · Reply
HIGHTABLETRADES
HIGHTABLETRADES Jul. 24 at 5:36 PM
$MGX just bought in. I dig the science.
0 · Reply
Sibilance
Sibilance Jul. 24 at 3:15 PM
$MGX
0 · Reply
I_am_retail_investor
I_am_retail_investor Jul. 24 at 3:04 PM
$MGX - turn the volume up to $11 !
1 · Reply
bigpictureguy
bigpictureguy Jul. 24 at 2:17 PM
$MGX Moving today. Ample cash. Should be re-rated shortly.
0 · Reply